_edited.jpg)
Understanding Amniotic Membrane Technology
Amniotic membrane is a thin, resilient tissue derived from donated birth tissue. This remarkable biological material is rich in nutrients and growth factors that support natural healing processes. Its unique properties make it an invaluable resource in advanced wound care and regenerative medicine.
Key Properties
Amniotic membrane offers several beneficial characteristics:
-
Promotes rapid tissue healing
-
Reduces inflammation and discomfort
-
Minimizes scar formation
-
Provides a protective barrier for wounds
-
Supports tissue regeneration and repair
Composition
The healing power of amniotic membrane comes from its rich composition:
-
Collagen and elastin: Provide structure and flexibility
-
Growth factors: Stimulate cell growth and tissue repair
-
Cytokines: Regulate inflammation and immune response
-
Hyaluronic acid: Promotes hydration and cell movement
Medical Applications
At NuCell Solutions, we utilize amniotic membrane technology for various medical purposes:
​
-
Chronic wound treatment
-
Surgical recovery
-
Ophthalmological procedures
-
Tissue reconstruction
Discover the Beauty of Amniotic Grafting
How Does It Work?
-
Natural Healing Boost: Amniotic grafts contain growth factors and proteins that stimulate your body's own healing process.
-
Tissue Regeneration: The graft provides a scaffold for your cells to grow and rebuild damaged tissue.
-
Reduced Inflammation: Amniotic tissue has natural anti-inflammatory properties, helping to reduce pain and swelling.
-
Versatile Application: Can be used for various wound types, from diabetic ulcers to surgical sites.
The Procedure: Quick and Simple
-
Your doctor cleans the treatment area
-
The amniotic graft is applied directly to the wound
-
A protective dressing is placed over the graft
-
You're done! No surgery, no lengthy recovery time
Benefits of Amniotic Grafting
-
Non-invasive application
-
Minimal to no discomfort during treatment
-
Faster healing compared to traditional methods
-
Reduced risk of scarring
-
No risk of rejection, as the graft is specially processed
Is Amniotic Grafting Right for You?
Amniotic grafting can be an excellent option for:
-
Chronic non-healing wounds
-
Diabetic foot ulcers
-
Surgical wound healing
-
And many other applications!
ASK US ANYTHING!
Q & A
-
Section 1: Patient-Friendly Questions
Q: What is an amniotic graft?
A: It’s a special layer of tissue from the placenta that helps wounds heal faster. It is donated safely after
childbirth and carefully tested.
Q: Is it safe?
A: Yes. The tissue comes from healthy mothers during planned C-sections, and it is cleaned and
sterilized. The chance of rejection or infection is very low.
Q: Will it hurt when applied?
A: No. The graft is gently placed on your wound and covered with a bandage. Most patients feel no pain
during the process.
Q: How long does it take to work?
A: Many patients notice improvement within a few weeks, but healing depends on the size and
condition of your wound.
Q: How many treatments will I need?
A: Some people need only one, but most need weekly applications for several weeks.
Q: Will I need surgery?
A: No. The graft is applied in a clinic setting and does not require surgery.
Q: Can I walk or move around after treatment?
A: Yes, but your provider may ask you to limit certain movements to protect the wound.
Q: Can I shower or bathe with the graft?
A: You’ll usually need to keep the wound dry. Your provider will explain how to bathe safely during
treatment.
Q: What should I eat to help my wound heal?
A: Eating protein-rich foods, fruits, vegetables, and staying hydrated can help your body heal faster.
Q: Will I feel any side effects?
A: Most people do not. A few may notice mild irritation or extra drainage, but serious side effects are
rare.
Q: How do I take care of the dressing?
A: Keep it clean, dry, and covered as directed by your provider. Do not remove it early unless told to.
Q: Will insurance cover this treatment?
A: Medicare and many insurance plans cover amniotic grafts if your wound meets certain conditions.
Your provider’s office will help check coverage.
Q: What if my insurance does not cover it?
A: Your provider will discuss other options. Some patients may pay out-of-pocket or use alternate
treatments.
Q: Can this help diabetic foot ulcers?
A: Yes, amniotic grafts are commonly used for wounds caused by diabetes that do not heal with
standard care.
Q: Can it help with burns?
A: Yes, amniotic grafts can help certain types of burns heal faster and with less scarring.
Q: Will the graft come from my own body?
A: No, it is donated tissue from healthy mothers after childbirth. It is safe and carefully tested.
Q: Do I need to prepare before treatment?
A: Not usually. Your provider may clean or measure the wound before applying the graft.
Q: What happens if the graft doesn’t work?
A: Your provider may try another application or suggest a different wound care method.
Q: How will I know it’s working?
A: You should notice the wound looking smaller, cleaner, and less painful over time.
Q: What should I do if my wound looks worse?
A: Contact your provider right away if you notice swelling, redness, fever, or unusual pain.
-
Section 2: Provider/Clinical Questions
Q: What exactly is an amniotic graft?
A: An amniotic graft is a type of tissue graft derived from the amniotic membrane, which is part of the placenta. It is used in wound healing and regenerative medicine because it contains growth factors that
promote tissue repair.
Q: Who are amniotic grafts typically used for?
A: They are commonly used for patients with chronic wounds, burns, diabetic ulcers, and other conditions that involve significant skin or tissue damage. They can also be used in surgical procedures for certain types of eye or oral surgeries.
Q: Why are amniotic grafts beneficial for wound care?
A: Amniotic grafts are beneficial because they provide a natural scaffold for healing, reduce
inflammation, lower the risk of infection, and promote faster recovery with less scarring compared to traditional dressings.
Q: Are amniotic grafts safe?
A: Yes. Amniotic grafts are screened, sterilized, and regulated by the FDA as human tissue products.They are sourced ethically from healthy mothers after planned cesarean deliveries, with consent. The risk of infection or rejection is very low.
Q: Do insurance plans cover amniotic grafts?
A: Coverage depends on the patient's insurance and diagnosis. Medicare and many Medicare
Advantage plans cover skin substitutes for certain chronic wounds when medical necessity criteria are met. Private insurance coverage varies and requires prior authorization in many cases.
Q: What documentation is needed for insurance approval?
A: Providers typically need wound care notes, prior conservative treatment history, and photographic evidence. The wound must generally be chronic, non-healing, and unresponsive to standard care
before insurance approves graft use.
Q: What should referring providers know?
A: Referring providers should ensure accurate diagnosis coding, provide complete patient history, and note previous wound care treatments. This information helps determine medical necessity and speeds
up insurance approval. Referrals can be coordinated with wound care specialists.
Q: How long does treatment with an amniotic graft last?
A: Treatment length varies depending on wound severity. Many patients require multiple weekly applications over several weeks until sufficient healing occurs.
Q: What should patients expect during treatment?
A: The graft is applied directly to the wound in a clinical setting. It is usually painless, covered with a protective dressing, and does not require surgery. Patients often notice improved healing and reduced
pain within weeks.
Section 3: Physician/Scientific Questions
Q: What biological properties make the amniotic membrane effective for wound
healing?
A: The amniotic membrane is rich in extracellular matrix proteins (collagen IV, V, VII; laminin; fibronectin) and growth factors such as VEGF, PDGF, EGF, and TGF-β. It also contains anti-inflammatory cytokines that modulate immune response, reduce fibrosis, and support epithelial migration.
Q: How does the amniotic graft interact with chronic wound pathology?
A: Chronic wounds are defined by persistent inflammation, excess protease activity, and poor oxygenation. Amniotic grafts downregulate inflammatory cytokines, reduce MMP activity, and promote angiogenesis, shifting the wound from a chronic inflammatory state to active regeneration.
Q: What cellular mechanisms are activated by amniotic grafts?
A: Amniotic grafts stimulate keratinocyte and fibroblast proliferation, enhance endothelial migration,
support stem cell homing, and promote angiogenesis via VEGF, while reducing scar-forming myofibroblasts.
Q: How does amniotic tissue compare with other biologic dressings?
A: Unlike acellular scaffolds or xenografts, amniotic grafts provide both structure and bioactive
signaling, making them uniquely effective in complex, non-healing wounds.
Q: In which types of wounds are amniotic grafts most effective?
A: They are effective in diabetic ulcers, venous ulcers, pressure injuries, burns, surgical dehiscence, and ocular surface reconstruction, especially after failure of standard moist therapy.
Q: What role do amniotic grafts play in post-radiation cancer wounds?
A: Post-radiation wounds arise from hypoxia, fibrosis, and microvascular loss. Amniotic grafts deliver pro-angiogenic factors, reduce fibrosis, and improve tissue pliability, supporting faster healing.
Q: What evidence supports their use in radiation-induced tissue necrosis?
A: Case series and translational studies suggest improved granulation and accelerated closure in
radiation wounds. Randomized controlled trial data is limited, but mechanistic evidence supports their adjunctive use.
Q: How do amniotic grafts reduce fibrosis and scarring in irradiated fields?
A: Amniotic tissue delivers MMP inhibitors and TGF-β modulators that reduce fibroblast hyperactivity, leading to softer, more pliable scar tissue.
Q: Are there contraindications to using amniotic grafts in irradiated wounds?
A: Yes. Active tumor recurrence is an absolute contraindication. Relative contraindications include uncontrolled infection, inadequate perfusion, or systemic malnutrition.
Q: How should grafts be applied in irradiated tissue compared to non-irradiated?
A: Necrotic tissue must be sharply debrided. Multiple weekly applications are often required, sometimes layered, and NPWT may improve integration.
Q: Where can patients receive amniotic graft treatment?
A: Treatment may occur in hospital outpatient wound centers, specialized wound clinics, skilled nursing facilities, physician offices, or in select home health cases under strict physician oversight.
Q: What qualifications should providers have when applying amniotic grafts?
A: Physicians, podiatrists, or APPs with wound care training should apply grafts. Certified wound nurses may assist.
Q: How often should patients return for graft application?
A: Typically weekly until significant healing, averaging 4–8 sessions, with reassessment at each visit.
Q: Can patients with limited mobility receive grafts at home?
A: Yes, if performed by skilled home health nurses with sterile technique and physician oversight.
Q: How does insurance coverage vary by care setting?
A: Medicare and commercial payers reimburse in outpatient, wound clinic, and office settings. SNF and home health applications may face more restrictions.
Q: What improvements can clinicians expect in post-radiation wounds?
A: Reduced pain, improved granulation, faster epithelialization, and decreased infection. Full closure may be delayed, but functional improvement is common.
Q: How do grafts impact patient quality of life?
A: They reduce pain, drainage, and infection risk, improving mobility, hygiene, and emotional well-being.
Q: What adjunctive therapies may enhance results?
A: HBOT, NPWT, comorbidity optimization, and nutritional support improve graft performance.
Q: How many applications are typically required for irradiated wounds?
A: Irradiated wounds may require 6–10 applications compared to 3–6 in non-irradiated wounds.
Q: What long-term complications should providers monitor for?
A: Monitor for wound recurrence, fibrosis-related contractures, and signs of tumor recurrence. Ongoing
oncologic surveillance is essential.
​
​
​